Clinical Trials on Janus Kinase Inhibitors
Total 899 results
-
Groupe Hospitalier Pitie-SalpetriereVanderbilt University Medical CenterCompleted
-
PfizerNot yet recruitingSkin Diseases | Immune System Diseases | Dermatitis | Eczema | Dermatitis, Atopic | Janus Kinase Inhibitors
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Northwestern UniversityCompletedCancer | Communication | Medication Adherence | Cancer, Treatment-Related | Tyrosine Kinase InhibitorUnited States
-
Sun Yat-sen UniversityRecruitingEGFR Tyrosine Kinase Inhibitors Plus VEGFR InhibitorsChina
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
AstraZenecaHutchinson MediPharma (HMP)Active, not recruitingKidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Neoplasms by Site | Kidney Diseases | Carcinoma | Enzyme Inhibitors | Protein Kinase InhibitorsUnited States, Italy, France, Korea, Republic of, Brazil, Russian Federation, Ukraine
-
Blueprint Medicines CorporationTerminatedNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | Non Small Cell Lung... and other conditionsUnited States
-
Shenzhen Second People's HospitalRecruitingChronic Myeloid Leukemia, Chronic Phase | Olverembatinib | Tyrosine Kinase InhibitorsChina
-
French Innovative Leukemia OrganisationBristol-Myers SquibbCompletedSmall Lymphocytic Leukemia | CLL, Relapsed | CLL, Refractory | Bruton Tyrosine Kinase InhibitorFrance
-
Namik Kemal UniversityNot yet recruitingCan the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 InhibitorsTurkey
-
Sichuan Cancer Hospital and Research InstituteRecruitingLiver Diseases | Digestive System Neoplasms | Liver Neoplasms | Hepatocellular Carcinoma | Antineoplastic Agents | Molecular Mechanisms of Pharmacological Action | Protein Kinase Inhibitors | SorafenibChina
-
VA Office of Research and DevelopmentVHA Pharmacy Benefits Management Services VA Center For Medication SafetyCompletedEvaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program (RaPPID)Proton Pump InhibitorsUnited States
-
Ospedale Santa Croce-Carle CuneoUnknownPlatelet Aggregation Inhibitors
-
Moscow Regional Research and Clinical Institute...TerminatedGlycogen Synthase Kinase 3Russian Federation
-
Poitiers University HospitalRecruitingChronic Myeloid Leukemia | Tyrosine Kinase InhibitorsFrance
-
Sun Yat-sen UniversityActive, not recruitingHepatocellular Carcinoma (HCC) | Radiomics | Transcatheter Arterial Chemoembolization (TACE) | Microvascular Invasion (MVI) | Multi-kinase Inhibitors (MKI)China
-
Fujian Cancer HospitalRecruitingThyroid Cancer | Health Related Quality of Life | Tyrosine Kinase InhibitorChina
-
Cancer Institute and Hospital, Chinese Academy...CompletedThe Optimal Sequence of Radiotherapy and Systematic Tyrosine Kinase Inhibitors in Treating Brain MetastasesChina
-
Nantes University HospitalCompletedProton Pump Inhibitors | DeprescriptionFrance
-
Nantes University HospitalCompletedProton Pump Inhibitors | DeprescriptionFrance
-
Xinrui ZhuEnrolling by invitationHepatocellular Carcinoma Non-resectable | Tyrosine Kinase Inhibitor | Transarterial Chemoembolization | Immune Checkpoint BlockadeChina
-
Meir Medical CenterUnknownThe Combined Effect of Hsp90 Inhibitor and HDAC/Proteasome Inhibitors on Lung Cancer Cell Fate and ER-Golgi Homeostasis Will be Examined.Israel
-
Samsung Medical CenterCompletedAdherence, Medication | Percutaneous Coronary Intervention | Compliance, Medication | Platelet Aggregation Inhibitors | Hydroxymethylglutaryl-coa Reductase Inhibitors | Persistence, MedicationKorea, Republic of
-
Guangzhou JOYO Pharma Co., LtdRecruitingLung Neoplasms | Brain Neoplasms | Protein Kinase Inhibitors | Other Protocol Specified CriteriaChina
-
Hangzhou Cancer HospitalUnknownNon-small Cell Lung Cancer | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)China
-
Erasmus Medical CenterRecruitingNon Small Cell Lung Cancer | Liquid Biopsy | Tyrosine Kinase InhibitorNetherlands
-
Central Hospital, Nancy, FranceCompletedAdenocarcinoma of Lung Stage IV | Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in, SomaticFrance
-
Duke UniversityCompletedAspirin | Platelet Aggregation Inhibitors | Ticagrelor | RNAUnited States
-
Vanderbilt UniversityCompletedPhosphoglycerate Kinase (PGK) DeficiencyUnited States
-
National Taiwan University HospitalRecruitingPharmacokinetics | Therapeutic Drug Monitoring | Tyrosine Kinase InhibitorTaiwan
-
Ege UniversityCompletedComposite Resins | Matrix Metalloproteinase Inhibitors
-
Sun Yat-sen UniversityUnknownHydroxymethylglutaryl-CoA Reductase Inhibitors | Endothelium
-
Central Hospital, Nancy, FranceCompletedMuscular Diseases | Creatine KinaseFrance
-
Groupe Hospitalier Paris Saint JosephCompleted
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Prevention | Tissue Oxygenation | Empagliflozin | SGLT2-Inhibitors | Hematocrit ChangeGreece
-
Tianjin Medical University Cancer Institute and...RecruitingCarcinoma, Non-Small-Cell Lung | EGF-R Positive Non-Small Cell Lung Cancer | Bevacizumab | Tyrosine Kinase InhibitorChina
-
Institut BergoniéInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedCancer Treated With Immune-checkpoint InhibitorsFrance
-
Loulou FoundationActive, not recruitingCyclin-Dependent Kinase-Like 5 Deficiency DisorderUnited States, Spain, Italy, France, Canada, Germany, United Arab Emirates
-
Centre Hospitalier Universitaire, AmiensCentral Hospital Saint QuentinRecruitingImmunotherapy | Immune Checkpoint Inhibitors | Immune-related Adverse Event | Predictive BiomarkersFrance
-
Drexel UniversityCompletedInhibitory Control Training | GameifactionUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarotid Artery Plaque | Plaque, Atherosclerotic | Immune Checkpoint Inhibitors | Programmed Cell Death Protein 1 Inhibitor | Intimal Medial Thickness of Internal Carotid ArteryChina
-
Nanjing Medical UniversityCompletedImmune Checkpoint Inhibitor | Endocrine ToxicityChina
-
M.D. Anderson Cancer CenterRigel Pharmaceuticals,Inc.Not yet recruitingMutant IDH1 Inhibitor OlutasidenibUnited States
-
Gene SolutionsRecruitingNon Small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Stage IIIC Non-Small Cell Lung Cancer | Tyrosine Kinase InhibitorsVietnam
-
Hadassah Medical OrganizationCompletedDrug Interactions Between Clopidogrel and Serotonin Reuptake Inhibitors
-
Universidad Vina del MarCompletedContraceptive Usage | Diffuse Noxious Inhibitory ControlChile
-
Groupe Hospitalier Paris Saint JosephCompletedProton Pump InhibitorFrance
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina